Striatal 6-hydroxydopamine induces apoptosis of nigral neurons in the adult rat
- PMID: 12468044
- DOI: 10.1016/s0006-8993(02)03694-6
Striatal 6-hydroxydopamine induces apoptosis of nigral neurons in the adult rat
Abstract
The massive dopaminergic neuronal loss that occurs in Parkinson's disease shows features of apoptosis. In the current study we have characterised the neuronal death in an animal model of Parkinson's disease. 6-Hydroxydopamine infused in the striatum of adult rats induced progressive loss of dopamine neurons, identified as tyrosine hydroxylase immunoreactive profiles, in the ipsilateral substantia nigra starting at day 5 post-lesion (32%). Silver staining revealed the presence of apoptotic profiles with neuronal morphology in the substantia nigra ipsilateral to the intrastriatal 6-hydroxydopamine injection. These apoptotic nuclei were first observed at day 6 post-lesion, peaked between days 7 and 10 and then abruptly declined. The apoptotic morphology of 6-hydroxydopamine-induced neuronal death was confirmed by electron microscopic studies. These data show that intrastriatal 6-hydroxydopamine-induced dopaminergic neuronal death in the adult rat is apoptotic and supports the use of this lesion protocol as an animal model of Parkinson's disease.
Similar articles
-
NF-kappaB contributes to 6-hydroxydopamine-induced apoptosis of nigral dopaminergic neurons through p53.Brain Res. 2007 May 11;1145:190-203. doi: 10.1016/j.brainres.2007.01.130. Epub 2007 Feb 7. Brain Res. 2007. PMID: 17368433
-
Treadmill exercise suppresses nigrostriatal dopaminergic neuronal loss in 6-hydroxydopamine-induced Parkinson's rats.Neurosci Lett. 2007 Aug 9;423(1):12-7. doi: 10.1016/j.neulet.2007.06.031. Epub 2007 Jun 28. Neurosci Lett. 2007. PMID: 17644250
-
NAIP protects the nigrostriatal dopamine pathway in an intrastriatal 6-OHDA rat model of Parkinson's disease.Eur J Neurosci. 2001 Jul;14(2):391-400. doi: 10.1046/j.0953-816x.2001.01653.x. Eur J Neurosci. 2001. PMID: 11553289
-
Time-course of nigrostriatal degeneration in a progressive MPTP-lesioned macaque model of Parkinson's disease.Mol Neurobiol. 2003 Dec;28(3):209-18. doi: 10.1385/MN:28:3:209. Mol Neurobiol. 2003. PMID: 14709785 Review.
-
Dopaminergic cells of the carotid body: physiological significance and possible therapeutic applications in Parkinson's disease.Brain Res Bull. 2002 Apr;57(6):847-53. doi: 10.1016/s0361-9230(01)00771-7. Brain Res Bull. 2002. PMID: 12031283 Review.
Cited by
-
Neuronal degeneration and oxidative stress in the SNc of 6-OHDA intoxicated rats; improving role of silymarin long-term treatment.Naunyn Schmiedebergs Arch Pharmacol. 2020 Dec;393(12):2427-2437. doi: 10.1007/s00210-020-01954-7. Epub 2020 Jul 27. Naunyn Schmiedebergs Arch Pharmacol. 2020. Retraction in: Naunyn Schmiedebergs Arch Pharmacol. 2024 Jan;397(1):635. doi: 10.1007/s00210-023-02898-4. PMID: 32715318 Retracted.
-
The Parkinsonian mimetic, 6-OHDA, impairs axonal transport in dopaminergic axons.Mol Neurodegener. 2014 May 3;9:17. doi: 10.1186/1750-1326-9-17. Mol Neurodegener. 2014. PMID: 24885281 Free PMC article.
-
Expression of Tgfβ1 and Inflammatory Markers in the 6-hydroxydopamine Mouse Model of Parkinson's Disease.Front Mol Neurosci. 2016 Feb 3;9:7. doi: 10.3389/fnmol.2016.00007. eCollection 2016. Front Mol Neurosci. 2016. PMID: 26869879 Free PMC article.
-
Neurodegeneration models in Parkinson's disease: cellular and molecular paths to neuron death.Behav Brain Funct. 2025 May 31;21(1):14. doi: 10.1186/s12993-025-00279-w. Behav Brain Funct. 2025. PMID: 40450319 Free PMC article. Review.
-
AAV transduction of dopamine neurons with constitutively active Rheb protects from neurodegeneration and mediates axon regrowth.Mol Ther. 2012 Feb;20(2):275-86. doi: 10.1038/mt.2011.213. Epub 2011 Oct 18. Mol Ther. 2012. PMID: 22008911 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources